Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA panel to rate cooling catheter

This article was originally published in The Gray Sheet

Executive Summary

Circulatory System Devices Panel convenes March 17 in Gaithersburg, Md. to review a 510(k) submission for a device applying mild hypothermia to treat patients rendered unconscious by cardiac arrest. Alsius' CoolGard system, which uses a proprietary catheter to fill two MicroTherm cooling balloons in the superior vena cava, currently lacks the indication under review. [Editor's note: To order a webcast or DVD of the panel meeting, visit "The Gray Sheet" affiliate 1www.FDAAdvisoryCommittee.com.] Radiant Medical markets Reprieve, a second-gen version of the SetPoint endovascular temperature management system, cleared in 2002 for "cardiac surgery patients to achieve and/or maintain normothermia during surgery and recovery/intensive care." Panelists agreed last September that safety studies are needed to assess hypothermia as therapy for comatose patients after cardiac arrest (2"The Gray Sheet" Sept. 27, 2004, p. 5)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021677

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel